Vadivarhe Speciality Chemicals Limited - Income Statement (TTM)

Vadivarhe Speciality Chemicals Limited
IN ˙ NSEI
Income Statement (TTM)

Vadivarhe Speciality Chemicals Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
Revenue 260 254 267 242 226 241 218 276 335 389 443 407 370 388 405 407 408 395 381
Change (%) -2.41 4.92 -9.10 -6.90 6.92 -9.72 26.96 21.23 15.96 14.08 -8.29 -9.04 4.78 4.56 0.35 0.35 -3.26 -3.37
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 256 220 211 200 192 223 165 251 287 224 275 252 229 243 232 235 238 265 292
Change (%) -14.35 -4.11 -4.96 -4.26 16.10 -25.64 51.84 14.13 -21.88 22.90 -8.35 -9.11 5.80 -4.47 1.25 1.23 11.42 10.25
% of Revenue 98.49 86.45 79.01 82.61 84.96 92.26 75.99 90.88 85.56 57.65 62.10 62.06 62.01 62.62 57.21 57.72 58.23 67.06 76.51
Gross Operating Profit 4 34 56 42 34 19 52 25 48 165 168 154 141 145 173 172 170 130 90
Change (%) 778.26 62.49 -24.72 -19.47 -44.96 180.02 -51.79 91.99 240.16 2.09 -8.20 -8.93 3.11 19.69 -0.84 -0.85 -23.72 -31.10
% of Revenue 1.51 13.55 20.99 17.39 15.04 7.74 24.01 9.12 14.44 42.35 37.90 37.94 37.99 37.38 42.79 42.28 41.77 32.94 23.49
SG&A 43 40 39 38 38 40 44 45 46 46 44 43 42 44 46 50 54 56 58
Change (%) -6.54 -3.38 -1.71 -0.30 4.49 9.08 2.87 2.79 -0.88 -2.83 -2.21 -2.26 3.99 3.84 8.99 8.25 3.19 3.09
% of Revenue 16.61 15.91 14.65 15.84 16.97 16.58 20.04 16.23 13.76 11.77 10.02 10.69 11.48 11.40 11.32 12.29 13.26 14.14 15.09
R&D
Change (%)
% of Revenue
OpEx 322 285 290 278 270 305 302 339 376 400 425 401 377 378 378 385 392 421 450
Change (%) -11.61 1.62 -3.93 -2.81 12.82 -0.85 12.22 10.89 6.31 6.26 -5.66 -6.00 0.13 0.13 1.88 1.85 7.34 6.84
% of Revenue 123.79 112.13 108.60 114.78 119.83 126.44 138.86 122.75 112.28 102.94 95.88 98.63 101.92 97.40 93.28 94.70 96.11 106.65 117.92
Operating Income -62 -31 -23 -36 -45 -64 -85 -63 -41 -11 18 6 -7 10 27 22 16 -26 -68
Change (%) -50.26 -25.58 56.23 24.89 42.55 32.70 -25.68 -34.56 -72.22 -259.77 -69.47 -227.54 -241.39 170.73 -20.86 -26.36 -265.46 160.44
% of Revenue -23.79 -12.13 -8.60 -14.78 -19.83 -26.44 -38.86 -22.75 -12.28 -2.94 4.12 1.37 -1.92 2.60 6.72 5.30 3.89 -6.65 -17.92
Interest Expense -13 -12 -13 -14 -15 -16 -16 -16 -15 -15 -15 -14 -14 -14 -13 -13 -12 -13 -14
Change (%) -4.22 3.45 10.39 10.25 4.01 0.32 -2.80 -2.88 -0.94 -1.06 -2.15 -2.20 -2.74 -2.82 -5.17 -5.45 6.79 6.36
% of Revenue -4.87 -4.78 -4.71 -5.73 -6.78 -6.60 -7.33 -5.61 -4.50 -3.84 -3.33 -3.55 -3.82 -3.55 -3.30 -3.11 -2.93 -3.24 -3.57
Net Income -51 -12 -28 -41 -57 -77 -96 -75 -54 -20 11 -8 -28 -14 1 3 5 -44 -93
Change (%) -76.36 130.11 46.82 40.97 34.40 25.13 -21.76 -27.82 -62.40 -156.23 -170.86 241.13 -51.11 -104.54 363.62 78.43 -960.29 111.62
% of Revenue -19.48 -4.72 -10.35 -16.72 -25.32 -31.83 -44.12 -27.19 -16.19 -5.25 2.59 -2.00 -7.50 -3.50 0.15 0.70 1.25 -11.09 -24.29

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista